Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиMirati Therapeutics Мультипликаторы 2011-2024 | MRTX
Мультипликаторы по годам Mirati Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.5 | -13.1 | -27.6 | -15.3 | -20.5 | -9.1 | -1.2 | -5.6 | -6.4 | -4.4 | - | - |
P/S |
206.0 | 105.6 | 737.5 | 977.7 | 156.5 | - | - | - | - | - | - | - |
EPS |
-13.2 | -11.2 | -8.0 | -5.7 | -3.2 | -2.8 | -4.2 | -3.8 | -3.2 | -4.8 | -3 | - |
EV (Enterprise Value) |
2.53 млрд | 7.39 млрд | 9.11 млрд | 3.26 млрд | 2.02 млрд | 551 млн | 92.7 млн | 324 млн | 279 млн | 256 млн | -13 млн | -6.12 млн |
EBITDA per Share |
-13.5 | -11 | -8.2 | -5.92 | -3.32 | -2.82 | -4.22 | -3.82 | -2.86 | -2.78 | - | - |
EV/EBITDA |
-12.9 | -24.7 | -14.5 | -19.4 | -7.5 | -0.9 | -4.9 | -7.1 | -7.1 | - | - | |
PEG |
-0.09 | -0.48 | -1.23 | 0.2 | 1.39 | -0.27 | 0.12 | 0.32 | -0.2 | 0.03 | - | - |
P/B |
2.6 | 5.4 | 7.3 | 8.5 | 10.0 | 4.5 | 2.1 | 3.1 | 10.0 | 8.9 | - | - |
P/CF |
-4.5 | -19.6 | -36.4 | -21.8 | -28.8 | -10.0 | -1.5 | -7.1 | -8.4 | -7.8 | - | - |
ROE % |
-74.35 | -41.64 | -26.30 | -55.68 | -48.82 | -49.19 | -172.11 | -54.59 | -155.67 | -204.26 | - | - |
ROA % |
-61.60 | -36.62 | -24.25 | -49.25 | -43.08 | -44.82 | -131.05 | -50.39 | -130.48 | -81.93 | - | - |
ROCE % |
-76.22 | -41.03 | -27.14 | -57.95 | -50.73 | -49.81 | -172.95 | -54.74 | -138.06 | -52.18 | - | - |
Current Ratio |
5.8 | 8.3 | 12.8 | 8.7 | 8.7 | 11.4 | 4.0 | 12.8 | 6.1 | 12.2 | - | - |
DSO |
12.7 | - | - | 171.4 | 21.7 | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
12.7 | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
12.7 | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Mirati Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.49 | -3.04 | -3.18 | - | -3.09 | -3.18 | -3.4 | -3.72 | -1.55 | -3.23 | -2.67 | -2.08 | -1.96 | -1.89 | -2.02 | -1.83 | -1.38 | -1.26 | -1.17 | -0.87 | -0.85 | -0.94 | -0.51 | -0.67 | -0.65 | -0.74 | -0.73 | -0.99 | -0.97 | -1.11 | -1.13 | -0.96 | -1.11 | -0.95 | -0.77 | - | - | - | - | - | - | - | - | - | -0.93 | -0.73 | - | - | - | - | - |
EBITDA per Share |
-2.64 | -3.21 | -3.32 | - | -3.28 | -3.19 | -3.31 | -3.56 | -1.52 | -3.19 | -2.6 | -2.11 | -1.98 | -1.93 | -2.08 | -1.89 | -1.45 | -1.31 | -1.22 | -0.91 | -0.89 | -0.96 | -0.53 | -0.64 | -0.66 | -0.74 | -0.74 | -1 | -0.98 | -1.11 | -1.14 | -0.96 | -1.11 | -0.95 | -0.77 | -0.77 | -0.78 | -0.75 | -0.59 | -0.59 | -0.92 | -0.69 | -0.8 | - | -0.92 | -0.73 | - | - | - | - | - |
ROE % |
-78.15 | -76.41 | -68.01 | -46.32 | -60.61 | -52.62 | -51.50 | -47.19 | -40.33 | -39.36 | -30.71 | -26.30 | -37.81 | -45.59 | -51.45 | -55.78 | -50.88 | -50.36 | -52.23 | -48.82 | -47.29 | -45.02 | -44.00 | -49.15 | -77.49 | -106.28 | -139.15 | -172.05 | -146.81 | -122.47 | -89.88 | -54.62 | -76.05 | -90.90 | -117.16 | -155.72 | -232.28 | -315.14 | -306.76 | -160.82 | -178.09 | -81.80 | -64.43 | -30.87 | -30.87 | -13.59 | - | - | - | - | - |
ROA % |
-64.84 | -63.83 | -57.75 | -39.83 | -52.39 | -32.21 | -44.48 | -41.05 | -35.34 | -34.87 | -28.20 | -24.25 | -34.15 | -40.79 | -45.75 | -49.34 | -44.97 | -44.48 | -46.11 | -43.08 | -42.08 | -40.42 | -39.88 | -44.79 | -64.50 | -84.71 | -107.82 | -131.01 | -114.31 | -98.34 | -75.63 | -50.42 | -67.06 | -78.16 | -99.06 | -130.52 | -145.05 | -164.86 | -144.31 | -64.50 | -79.44 | -48.83 | -48.16 | -26.69 | -26.69 | -11.75 | - | - | - | - | - |
ROCE % |
-82.85 | -81.19 | -71.43 | -47.19 | -61.30 | -52.12 | -50.73 | -46.50 | -40.21 | -39.39 | -31.08 | -27.14 | -38.85 | -47.26 | -53.49 | -58.10 | -53.29 | -52.72 | -54.48 | -50.91 | -48.91 | -46.14 | -44.91 | -49.92 | -78.30 | -107.25 | -140.26 | -173.42 | -147.97 | -123.28 | -90.40 | -54.76 | -76.33 | -98.07 | -121.06 | -139.35 | -132.60 | -130.59 | -121.12 | -123.62 | -110.49 | -92.25 | -79.35 | -31.09 | -31.09 | -13.76 | - | - | - | - | - |
Current Ratio |
6.2 | 4.9 | 6.0 | 5.8 | 7.5 | - | 8.3 | 8.3 | 7.4 | 6.0 | 11.4 | 12.8 | 12.8 | 12.8 | 12.8 | 8.7 | 8.7 | 8.7 | 8.7 | 8.5 | 8.5 | 8.5 | 8.5 | 11.3 | 11.3 | 11.3 | 11.3 | 4.2 | 4.2 | 4.2 | 4.2 | 13.0 | 13.0 | 13.0 | 13.0 | 6.2 | 6.2 | 6.2 | 6.2 | 1.7 | 1.7 | 1.7 | 1.7 | 7.4 | 7.4 | 7.4 | - | - | - | - | - |
DSO |
70.0 | 55.8 | 45.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
70.0 | 55.8 | 45.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
70.0 | 55.8 | 45.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD